Product Information

IMVEXXY 10 MCG MAINTENANCE PAK is a brand product labeled by Mayne Pharma, priced at $27.0520 per EA under NDC 68308074808. Its NADAC has been published 85 times since Apr 9, 2025.

FDA first approved this application on May 29, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

IMVEXXY 10 MCG MAINTENANCE PAK

estradiol
$27.0520per EA
High Outlier

Strength

10 ug/1

Manufacturer

Mayne Pharma

NDC

68308074808

Classification

Brand

Dosage Form

INSERT

Route

VAGINAL

Effective Date

11/18/2026

Active Ingredients

ESTRADIOL

Approval Type

New Drug (NDA)

FDA Application

NDA208564

FDA Approved

5/29/2018

TE Code

AB

On Market Since

12/15/2023

Pharmacological Classes

Estradiol Congeners
Estrogen Receptor Agonists
Estrogen

Price Statistics

The NADAC for IMVEXXY 10 MCG MAINTENANCE PAK has been published 85 times since Apr 9, 2025, and over the history we have for it it has risen 4.6%. The table below summarizes its recorded NADAC range and movement.

Current price$27.0520 per EA
All-time high$27.0902 (Oct 14, 2026)
All-time low$25.7671 (Feb 18, 2026)
52-week high$27.0902
52-week low$25.7671
Median price$25.8161
Average price$26.1776
Largest weekly change+5.0% (Jun 3, 2026)
Weeks tracked85
Tracking sinceApr 9, 2025

Price History

1W

+0.3%

1M

-0.1%

3M

-0.1%

6M

+4.9%

1Y

+4.9%

3Y

N/A

5Y

N/A

All

+4.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IMVEXXY 10 MCG MAINTENANCE PAK?

The current National Average Drug Acquisition Cost (NADAC) for IMVEXXY 10 MCG MAINTENANCE PAK, manufactured by Mayne Pharma, is $27.0520 per EA (NDC 68308074808), effective Nov 18, 2026.

How has the price of IMVEXXY 10 MCG MAINTENANCE PAK changed over time?

Over the history we have for it, the NADAC for IMVEXXY 10 MCG MAINTENANCE PAK has risen 4.6%. It has been tracked across 85 weekly CMS publications since Apr 9, 2025.

What are the highest and lowest recorded NADAC prices for IMVEXXY 10 MCG MAINTENANCE PAK?

Since Apr 9, 2025, the NADAC for IMVEXXY 10 MCG MAINTENANCE PAK has ranged from a low of $25.7671 (Feb 18, 2026) to a high of $27.0902 (Oct 14, 2026), with a median of $25.8161 per EA.

Are there cheaper alternatives to IMVEXXY 10 MCG MAINTENANCE PAK?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VAGIFEM 10 MCG VAGINAL TAB, is $20.3231 per EA — about 25% below IMVEXXY 10 MCG MAINTENANCE PAK.

Who manufactures IMVEXXY 10 MCG MAINTENANCE PAK?

IMVEXXY 10 MCG MAINTENANCE PAK (NDC 68308074808) is labeled by Mayne Pharma, and CMS classifies it as a brand product.